Daniel Janney, Director at Krystal Biotech, Inc. (KRYS), bought 324,456 shares at $10.00 ($2.0M) on 2017-09-22, disclosed to the SEC on 2017-09-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 124,456 | $0 | 0.0% |
| 2 | $10.00 | 200,000 | $2.0M | 100.0% |
| Total | $6.16 avg | 324,456 | $2.0M | 100% |
| Filing → |
| KRYS | SELL | 2023-06-09 | $8.3M | — | Filing → |
| KRYS | SELL | 2023-05-23 | $4.8M | — | Filing → |
| KRYS | SELL | 2023-05-11 | $1.6M | — | Filing → |